Total Payments
$6,468
2024 Payments
$864.35
Companies
44
Transactions
466
Medicare Patients
2,984
Medicare Billing
$234,307
Payment Breakdown by Category
Food & Beverage$6,423 (99.3%)
Education$45.66 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,423 | 463 | 99.3% |
| Education | $45.66 | 3 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $965.90 | 62 | $0 (2024) |
| ABBVIE INC. | $823.72 | 73 | $0 (2024) |
| Astellas Pharma US Inc | $543.45 | 36 | $0 (2024) |
| PFIZER INC. | $512.64 | 38 | $0 (2024) |
| Novo Nordisk Inc | $489.50 | 44 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $400.19 | 38 | $0 (2022) |
| Amgen Inc. | $390.91 | 23 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $220.12 | 15 | $0 (2020) |
| Lilly USA, LLC | $182.17 | 14 | $0 (2024) |
| Abbott Laboratories | $178.43 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $864.35 | 54 | GlaxoSmithKline, LLC. ($287.18) |
| 2023 | $752.88 | 53 | ABBVIE INC. ($265.01) |
| 2022 | $1,034 | 69 | GlaxoSmithKline, LLC. ($239.85) |
| 2021 | $731.92 | 52 | AbbVie Inc. ($211.06) |
| 2020 | $448.36 | 31 | Astellas Pharma US Inc ($62.03) |
| 2019 | $695.90 | 59 | Amgen Inc. ($166.60) |
| 2018 | $748.21 | 57 | Novo Nordisk Inc ($119.43) |
| 2017 | $1,193 | 91 | Janssen Pharmaceuticals, Inc ($265.76) |
All Payment Transactions
466 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.65 | General |
| Category: Cardiovascular | ||||||
| 11/18/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: Biological | ||||||
| 11/08/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $4.34 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: VACCINES | ||||||
| 11/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: RESPIRATORY | ||||||
| 10/30/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: Diabetes Care | ||||||
| 10/29/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $18.03 | General |
| Category: NEUROLOGY | ||||||
| 10/28/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: RESPIRATORY | ||||||
| 10/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.56 | General |
| Category: NEUROSCIENCE | ||||||
| 09/30/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: RESPIRATORY | ||||||
| 09/16/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: VACCINES | ||||||
| 09/10/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: VACCINES | ||||||
| 08/29/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: RESPIRATORY | ||||||
| 08/27/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Biological | ||||||
| 08/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: RESPIRATORY | ||||||
| 08/23/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Oncology | ||||||
| 08/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.58 | General |
| Category: NEUROSCIENCE | ||||||
| 08/12/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $27.43 | General |
| Category: NEUROSCIENCE | ||||||
| 08/02/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: Diabetes Care | ||||||
| 07/24/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: NEUROSCIENCE | ||||||
| 07/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: RESPIRATORY | ||||||
| 07/19/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Diabetes | ||||||
| 07/18/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: Biological | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 687 | 798 | $123,812 | $55,706 |
| 2022 | 10 | 722 | 864 | $136,344 | $62,340 |
| 2021 | 9 | 806 | 956 | $137,056 | $61,617 |
| 2020 | 12 | 769 | 922 | $139,396 | $54,643 |
Total Patients
2,984
Total Services
3,540
Medicare Billing
$234,307
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 175 | 175 | $43,750 | $21,121 | 48.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 117 | 156 | $32,136 | $12,095 | 37.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 21 | 21 | $13,860 | $5,936 | 42.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 68 | 68 | $7,208 | $4,871 | 67.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 71 | 90 | $12,600 | $4,682 | 37.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 79 | 80 | $3,360 | $2,319 | 69.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 14 | 14 | $3,752 | $2,176 | 58.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 104 | 156 | $5,616 | $1,485 | 26.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 27 | 27 | $1,134 | $782.73 | 69.0% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 11 | 11 | $396.00 | $239.28 | 60.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 189 | 189 | $47,250 | $23,423 | 49.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 151 | 231 | $47,586 | $17,896 | 37.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 80 | 83 | $8,798 | $5,669 | 64.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 21 | 21 | $5,628 | $3,363 | 59.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 11 | 11 | $7,260 | $3,048 | 42.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 88 | 91 | $3,822 | $2,489 | 65.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 39 | 43 | $6,020 | $2,487 | 41.3% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 14 | 14 | $3,332 | $1,838 | 55.2% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 107 | 159 | $5,724 | $1,524 | 26.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 22 | 22 | $924.00 | $602.44 | 65.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 211 | 211 | $52,750 | $26,814 | 50.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 163 | 230 | $47,380 | $18,097 | 38.2% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 122 | 123 | $13,038 | $8,006 | 61.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 135 | 136 | $5,712 | $2,152 | 37.7% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 15 | 15 | $3,098 | $1,865 | 60.2% |
About Dr. Shawn Hall, M.D
Dr. Shawn Hall, M.D is a Family Medicine healthcare provider based in Gonzales, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1306844147.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shawn Hall, M.D has received a total of $6,468 in payments from pharmaceutical and medical device companies, with $864.35 received in 2024. These payments were reported across 466 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($6,423).
As a Medicare-enrolled provider, Hall has provided services to 2,984 Medicare beneficiaries, totaling 3,540 services with total Medicare billing of $234,307. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Gonzales, LA
- Active Since 07/13/2005
- Last Updated 03/23/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1306844147
Products in Payments
- TRELEGY ELLIPTA (Drug) $662.64
- VRAYLAR (Drug) $344.06
- UBRELVY (Drug) $318.79
- Ozempic (Drug) $247.37
- XARELTO (Drug) $202.45
- MYRBETRIQ (Drug) $199.22
- INVOKANA (Drug) $191.72
- Myrbetriq (Drug) $177.16
- QULIPTA (Drug) $168.93
- Veozah (Drug) $154.63
- CHANTIX (Drug) $151.47
- TOUJEO (Drug) $151.04
- SHINGRIX (Biological) $142.97
- Aimovig (Biological) $141.04
- Saxenda (Drug) $137.87
- ENTRESTO (Drug) $122.68
- ELIQUIS (Drug) $121.70
- JARDIANCE (Drug) $118.47
- FREESTYLE LIBRE 3 (Device) $114.63
- FARXIGA (Drug) $107.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Gonzales
Robert St. Amant, M.d, M.D
Family Medicine — Payments: $236,984
Family Medicine $236,984
Dr. Ericka Flood, M.d, M.D
Family Medicine — Payments: $15,507
Family Medicine $15,507
Richard Caro, M.d, M.D
Family Medicine — Payments: $9,983
Family Medicine $9,983
Dr. Michael Bodin, Md, MD
Family Medicine — Payments: $8,621
Family Medicine $8,621
Gertrude Gboloo, M.d, M.D
Family Medicine — Payments: $7,934
Family Medicine $7,934
Dr. Garth Vaz, M.d, M.D
Family Medicine — Payments: $5,528
Family Medicine $5,528